Margaret Kyakuwa
Psychiatric/Mental Health · Spokane, WANPI 1669919023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,159 and has fallen 98.9% since, to $23 in 2025. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Novo Nordisk$555
- AbbVie$537
- AstraZeneca$471
- Lilly USA, LLC$241
- Astellas Pharma US Inc$212
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,760100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 59 | $1,047 |
| Novo Nordisk | 24 | $555 |
| AbbVie | 16 | $537 |
| AstraZeneca | 7 | $471 |
| Lilly USA, LLC | 9 | $241 |
| Astellas Pharma US Inc | 8 | $212 |
| Boehringer Ingelheim | 12 | $206 |
| Bayer | 6 | $196 |
| Medtronic | 1 | $167 |
| Johnson & Johnson | 5 | $160 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $126 |
| Edwards Lifesciences | 1 | $126 |
| Eisai Inc. | 1 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Mylan Specialty L.p. | 3 | $71 |
| Sanofi Pasteur Inc. | 2 | $61 |
| Dexcom, Inc. | 4 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| Genentech USA, Inc. | 3 | $26 |
| Exact Sciences | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Merck | 1 | $14 |
| Amgen | 1 | $14 |
| Pfizer | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$249
- FARXIGA$238
- UBRELVY$212
- COREVALVE EVOLUT R$167
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$126
- Leqembi$125
- MOUNJARO$124
- Veozah$123
- Kerendia$123
- BREZTRI$120
- VRAYLAR$104
How this compares
$4,760 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $11,864 |
| Trazodone Hcl | 20 | $754 |
| Rosuvastatin Calcium | 37 | $627 |
| Pantoprazole Sodium | 18 | $402 |
| Atorvastatin Calcium | 29 | $369 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $362 |
| Gabapentin | 21 | $308 |
| Levocetirizine Dihydrochloride | 22 | $302 |
| Levothyroxine Sodium | 21 | $268 |
| Losartan Potassium | 13 | $211 |
| Amlodipine Besylate | 27 | $188 |
| Montelukast Sodium | 16 | $177 |
| Sertraline Hcl | 12 | $154 |
| Metoprolol Succinate | 11 | $119 |
| Furosemide | 11 | $117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $206 | $11,86411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Spokane
- Dawn MasonSpokane$25K
- Favor OsakweSpokane$10K
- Colleen MooreSpokane$8K
- Nicholas GoodwinSpokane$5K
- Kiira TietjenSpokane$5K
- Angela HamelSpokane$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Jennifer WilsonYakima$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.